End-Of-Life Policy Solutions: A Cautionary Note

The optimistic stance regarding the impact of informed patient choice and transparency in reducing inappropriate care at the end of life may be warranted, but there are many forces pulling in the opposite direction.

July 10, 2017

Dichotomous Endings: A Physician’s Personal Reflection

As a critical care physician I have led countless resuscitations, and in empathizing with each patient and family, I often reflect on my grandparents. Why did two people die in such dramatically different ways?

June 8, 2017

Building Additional Serious Illness Measures Into Medicare Programs

Given that approximately 70 percent of people who die in the United States each year are Medicare beneficiaries, the new administration has an opportunity to implement changes to significantly improve the quality of end-of-life care.

May 25, 2017

The Humanity In End-Of-Life Care

Palliative care has been increasing in prevalence, in part due to new value-based care incentives. However, there is a significant misunderstanding about what defines effective palliative care among patients and providers.

May 19, 2017

Managing The Beginning Of The End: Advanced Disease Management And Concurrent Care Under Current Financing

If predicting six-month mortality is hard, trying to identify patients with life-limiting diagnoses who are candidates for “pre-hospice” services makes eligibility determinations even more ambiguous.

April 28, 2017

‘I’m Willing To Try Anything’: Compassionate Use Access To Experimental Drugs And The Misguided Mission Of Right-To-Try Laws

Pharmaceutical companies, not the FDA, are the true gatekeepers for their proprietary products. Policymakers must take this into account and incentivize pharmaceutical companies to provide greater access to their products in development.

March 27, 2017

A Call To The Palliative Care Community For A Patient-Centered Response To Medical Aid In Dying

The palliative care community and medical establishment must embrace patients' desires for self-determination and autonomy by supporting medical aid in dying as a legitimate medical option for dying patients.

March 15, 2017

How Do We Protect Patients From False Promises In Right-To-Try Laws?

Legislation before Congress seeks to grant all terminally ill patients the “Right to Try” experimental therapies once approved alternatives have failed. In its current form, however, Right to Try may be more likely to hurt patients rather than help them.

March 14, 2017

Innovation In Serious Illness Care Payment: Progress To Date And Opportunities For The New Administration

Discern Health recently developed a framework of principles for payment models to promote the delivery of community-based, comprehensive, high-quality, affordable serious illness care. Here are some key opportunities for policymakers to continue progress toward high-value care for the seriously ill.

March 8, 2017

Misleading Metrics

Metrics are intended to promote quality. But if they measure the wrong thing or are easy to manipulate, there can be serious consequences.

February 21, 2017